Spineway SA engages in the design, manufacture, and marketing of implants and surgical instruments for treating disorder of spinal column. The company offers ayers rock, an anterior cervical interbody fusion cage; blue mountain, an anterior cervical interbody fusion plate; mont blanc, a posterior thoracolumbar pedicle screws; mont blanc baby, a pediatric growing rod system; mont blanc 3d+, a coplanar alignment system; posterior osteosynthesis systems; kili, an anterior lumbar interbody fusion cage; twin peaks plif posterior lumbar interbody fusion cages; twin peaks tlif transforaminal lumbar interbody fusion cages; and mont blanc mis, a mini-invasive thoracolumbar system. It also provides neve, a biomaterial bone substitute for bone regeneration; and cervical and lumbar prosthesis elastic spine pads. In addition, the company exports its products. Spineway SA was incorporated in 2005 and is headquartered in Ecully, France.
Stock data | 2023 | Change |
---|---|---|
Price | $0.09017085605487836 | N/A |
Market Cap | $1.44M | N/A |
Shares Outstanding | 15.94M | -99.93% |
Employees | 53.00 | N/A |
Valuation | 2023 | Change |
---|---|---|
P/E Ratio | -221.01 | N/A |
P/S Ratio | 0.13 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $10.90M | N/A |
Earnings | -$6.75M | N/A |
EPS | -0.0004 | N/A |
Earnings Yield | -0.0045 | N/A |
Gross Margin | 0.7489 | N/A |
Operating Margin | -0.4294 | N/A |
Net income margin | -0.6189 | N/A |